TY - JOUR
T1 - Thromboembolic and bleeding events in ICU patients with COVID-19 - a nationwide, observational study
AU - Russell, Lene
AU - Weihe, Sarah
AU - Madsen, Emilie Kabel
AU - Hvas, Christine Lodberg
AU - Leistner, Jens Wolfgang
AU - Michelsen, Jens
AU - Brøchner, Anne Craveiro
AU - Bastiansen, Anders
AU - Mølgaard Nielsen, Frederik
AU - Meier, Nick
AU - Andreasen, Anne Sofie
AU - Ribergaard, Niels-Erik
AU - Rasmussen, Bodil Steen
AU - Sølling, Christoffer Grant
AU - Buck, David Levarett
AU - Bundgaard, Helle
AU - Pedersen, Helle Scharling
AU - Darfelt, Iben Strøm
AU - Poulsen, Lone Musaeus
AU - Ibsen, Michael
AU - Plovsing, Ronni R
AU - Sigurdsson, Sigurdur T
AU - Iversen, Susanne
AU - Hildebrandt, Thomas
AU - Mohr, Thomas
AU - Espelund, Ulrick Skipper
AU - Jørgensen, Vibeke
AU - Haase, Nicolai
AU - Perner, Anders
N1 - This article is protected by copyright. All rights reserved.
PY - 2023/1
Y1 - 2023/1
N2 - BACKGROUND: Intensive care unit (ICU) patients with Coronavirus disease 2019 (COVID-19) have an increased risk of thromboembolic complications. We describe the occurrence of thromboembolic and bleeding events in all ICU patients with COVID-19 in Denmark during the first and second waves of the pandemic.METHODS: This was a sub-study of the Danish Intensive Care Covid database, in which all patients with SARS-CoV-2 admitted to Danish ICUs from 10th March 2020 to 30th June 2021 were included. We registered coagulation variables at admission, and all thromboembolic and bleeding events, and the use of heparins during ICU stay. Variables associated with thrombosis and bleeding and any association with 90-day mortality were estimated using Cox regression analyses.RESULTS: We included 1369 patients in this sub-study; 158 (12%, 95% confidence interval 10-13) had a thromboembolic event in ICU and 309 (23%, 20-25) had a bleeding event, among whom 81 patients (6%, 4.8-7.3) had major bleeding. We found that mechanical ventilation and increased D-dimer were associated with thrombosis and mechanical ventilation, low platelet count and presence of haematological malignancy were associated with bleeding. Most patients (76%) received increased doses of thromboprophylaxis during their ICU stay. Thromboembolic events were not associated with mortality in adjusted analysis (hazard ratio 1.35 [0.91-2.01, p = .14], whereas bleeding events were 1.55 [1.18-2.05, p = .002]).CONCLUSIONS: Both thromboembolic and bleeding events frequently occurred in ICU patients with COVID-19. Based on these data, it is not apparent that increased doses of thromboprophylaxis were beneficial.
AB - BACKGROUND: Intensive care unit (ICU) patients with Coronavirus disease 2019 (COVID-19) have an increased risk of thromboembolic complications. We describe the occurrence of thromboembolic and bleeding events in all ICU patients with COVID-19 in Denmark during the first and second waves of the pandemic.METHODS: This was a sub-study of the Danish Intensive Care Covid database, in which all patients with SARS-CoV-2 admitted to Danish ICUs from 10th March 2020 to 30th June 2021 were included. We registered coagulation variables at admission, and all thromboembolic and bleeding events, and the use of heparins during ICU stay. Variables associated with thrombosis and bleeding and any association with 90-day mortality were estimated using Cox regression analyses.RESULTS: We included 1369 patients in this sub-study; 158 (12%, 95% confidence interval 10-13) had a thromboembolic event in ICU and 309 (23%, 20-25) had a bleeding event, among whom 81 patients (6%, 4.8-7.3) had major bleeding. We found that mechanical ventilation and increased D-dimer were associated with thrombosis and mechanical ventilation, low platelet count and presence of haematological malignancy were associated with bleeding. Most patients (76%) received increased doses of thromboprophylaxis during their ICU stay. Thromboembolic events were not associated with mortality in adjusted analysis (hazard ratio 1.35 [0.91-2.01, p = .14], whereas bleeding events were 1.55 [1.18-2.05, p = .002]).CONCLUSIONS: Both thromboembolic and bleeding events frequently occurred in ICU patients with COVID-19. Based on these data, it is not apparent that increased doses of thromboprophylaxis were beneficial.
KW - bleeding
KW - COVID-19
KW - thromboprophylaxis
KW - thrombosis
UR - http://www.scopus.com/inward/record.url?scp=85141525308&partnerID=8YFLogxK
U2 - 10.1111/aas.14157
DO - 10.1111/aas.14157
M3 - Journal article
C2 - 36263897
SN - 0001-5172
VL - 67
SP - 76
EP - 85
JO - Acta Anaesthesiologica Scandinavica
JF - Acta Anaesthesiologica Scandinavica
IS - 1
ER -